Board member Anne Altmeyer adopts 10b5-1 plan to sell up to 2,452 shares of CRBP common stock

Corbus Pharmaceuticals Holdings, Inc.

Anne Altmeyer, Ph.D., board member, adopted Rule 10b5-1 plan on Nov 14, 2024.
Plan allows sale of up to 2,452 shares of common stock.
Sales may begin on February 13, 2025; plan terminates December 31, 2025.
Plan is intended to satisfy affirmative defense under Rule 10b5-1(c).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.